Natural immunity appears to be as good as or better than vaccine immunity.

It has been shown now that the vaccinated equally catch and spread the virus. Vaccine side effect data continues to accumulate that make the risk of taking the vaccine prohibitive as the pandemic wanes. Oral and IV medications ( that work early in the treatment of COVID-19 are much more attractive to take now as the vaccine risks are becoming known, especially because the vaccinated will need endless boosters every six months.

Article: The Unvaccinated Are Looking Smarter Every Week

“Health Ministry data on the wave of COVID outbreaks which began this May show that Israelis with immunity from natural infection were far less likely to become infected again in comparison to Israelis who only had immunity via vaccination.”

Natural infection vs vaccination: Which gives more protection?

In May, median Ct values were lower in specimens from unvaccinated persons than in those from partially vaccinated and
fully vaccinated persons for the ORF1ab gene target (22.8,
36.6, and 27.7, respectively) and N gene target (24.0, 36.0, and
30.6, respectively); however, in July, no differences were found
by vaccination status among the gene targets

SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years,
by Vaccination Status — Los Angeles County, California, May 1–July 25, 2021

“SARS-CoV-2-naïve vaccinees had a 13.06-fold (95% CI, 8.08 to 21.11) increased risk for breakthrough infection with the Delta variant compared to those previously infected, when the first event (infection or vaccination) occurred during January and February of 2021. The increased risk was significant (P<0.001) for symptomatic disease as well.”

Study: Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections

“plasma from previously infected vaccinated individuals displayed overall better neutralization capacity when compared to plasma from uninfected individuals that also received two vaccine doses.”

Study: Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity

“individual memory antibodies selected over time by natural infection have greater potency and breadth than antibodies elicited by vaccination”

Study: Anti-SARS-CoV-2 receptor binding domain antibody evolution after mRNA vaccination

“COVID-19 was less frequent among placebo recipients with positive N-binding antibodies at study entry (7/542; ~1.3% attack rate) than among those without evidence of infection at study entry (1015/21,521; ~4.7% attack rate), indicating ~72.6% protection by previous infection.”

Study: Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

“In a Cox proportional hazards regression model, after adjusting for the phase of the epidemic, vaccination was associated with a significantly lower risk of SARS-CoV-2 infection among those not previously infected (HR 0.031, 95% CI 0.015 to 0.061) but not among those previously infected (HR 0.313, 95% CI 0 to Infinity). Conclusions” Individuals who have had SARS-CoV-2 infection are unlikely to benefit from COVID-19 vaccination, and vaccines can be safely prioritized to those who have not been infected before.”

Necessity of COVID-19 vaccination in previously infected individuals

How Long Does Vaccine Immunity Last?